NASDAQ

Alaunos Therapeutics, Inc. (TCRT)

♥ 577 Thanks from members

Live price chart, market sentiment, and community perspectives for Alaunos Therapeutics, Inc. (NASDAQ: TCRT).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Steven A. RosenbergFounder: Nicholas RestifoLeadership: Kandice A. Browning (CEO)Holder: Intrexon CorporationHolder: Institutional HoldersTCR-T Cell TherapiesE7-targeted Therapies#TCRT#Alaunos Therapeutics#Cancer Immunotherapy#T-Cell Receptor#NASDAQ TCRT